Currently, there are 90.39M common shares owned by the public and among those 89.46M shares have been available to trade.
The company’s stock has a 5-day price change of 13.19% and -35.83% over the past three months. ACHC shares are trading -32.06% year to date (YTD), with the 12-month market performance down to -61.78% lower. It has a 12-month low price of $20.36 and touched a high of $82.40 over the same period. ACHC has an average intraday trading volume of 2.59 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 15.69%, 1.16%, and -42.35% respectively.
Institutional ownership of Acadia Healthcare Company Inc (NASDAQ: ACHC) shares accounts for 111.14% of the company’s 90.39M shares outstanding.
It has a market capitalization of $2.48B and a beta (3y monthly) value of 0.99. The stock’s trailing 12-month PE ratio is 13.22, while the earnings-per-share (ttm) stands at $2.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.74% over the week and 5.89% over the month.
Earnings per share for the fiscal year are expected to decrease by -19.68%, and 12.16% over the next financial year. EPS should shrink at an annualized rate of -1.50% over the next five years, compared to 17.49% over the past 5-year period.
Looking at the support for the ACHC, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on February 28, 2025, with the firm’s price target at $43-$35. KeyBanc Capital Markets coverage for the Acadia Healthcare Company Inc (ACHC) stock in a research note released on January 07, 2025 offered a Overweight rating with a price target of $70. Deutsche Bank on their part issued Hold rating on April 25, 2024.
